Noninvasive early prediction of preeclampsia in pregnancy using retinal vascular features

Authors:

Top Cited Papers
Open Access
Abstract
Preeclampsia (PE), a severe hypertensive disorder during pregnancy, significantly contributes to maternal and neonatal mortality. Existing prediction biomarkers are often invasive and expensive, hindering their widespread application. This study introduces PROMPT (Preeclampsia Risk factor + Ophthalmic data + Mean arterial pressure Prediction Test), an AI-driven model leveraging retinal photography for PE prediction, registered at ChiCTR (ChiCTR2100049850) in August 2021. Analyzing 1812 pregnancies before 14 gestational weeks, we extracted retinal parameters using a deep learning system. The PROMPT achieved an AUC of 0.87 (0.83–0.90) for PE prediction and 0.91 (0.85–0.97) for preterm PE prediction using machine learning, significantly outperforming the baseline model (p < 0.001). It also improved detection of severe adverse pregnancy outcomes from 35% to 41%. Economically, PROMPT was estimated to avert 1809 PE cases and saved over $50 million per 100,000 screenings. These results position PROMPT as a non-invasive and cost-effective tool for prenatal care, especially valuable in low- and middle-income countries.
Funding Information
  • Guangzhou Clinical Major Technology Project (2024P-ZD12)
  • Sun Yat-Sen University Clinical Research 5010 Program (2022003)
  • the national key Research and Development Program of China (2021YFC2700700)
  • Guangdong Provincial Natural Science Foundation for Progressive Young Scholars (2023A1515030170)
  • National Natural Science Foundation of China (92368205)
  • The Science and Technology Planning Projects of Guangdong Province (2018B010109008)

This publication has 47 references indexed in Scilit: